Cara Therapeutics (CARA)
NASDAQ:CARA
Holding CARA?
Track your performance easily

Cara Therapeutics (CARA) Technical Analysis

2,258 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Cara Therapeutics’s (CARA) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting Cara Therapeutics is a Sell.
Cara Therapeutics’s (CARA) 20-Day exponential moving average is 0.29, while Cara Therapeutics’s (CARA) share price is $0.34, making it a Buy.
Cara Therapeutics’s (CARA) 50-Day exponential moving average is 0.30, while Cara Therapeutics’s (CARA) share price is $0.34, making it a Buy.

Cara Therapeutics (CARA) Pivot Points

Nov 10, 2024, 12:30 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.27
0.29
0.32
0.34
0.36
0.38
0.41
Fibonacci
0.29
0.31
0.32
0.34
0.35
0.36
0.38
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cara Therapeutics (CARA) Moving Averages

Nov 10, 2024, 12:30 AM
Period
Simple
Exponential
MA5
0.31Buy
0.32Buy
MA10
0.30Buy
0.31Buy
MA20
0.28Buy
0.29Buy
MA50
0.29Buy
0.30Buy
MA100
0.31Buy
0.36Sell
MA200
0.52Sell
0.51Sell
Cara Therapeutics’s (CARA) 10-Day exponential moving average is 0.31, while Cara Therapeutics’s (CARA) share price is $0.34, making it a Buy.
Cara Therapeutics’s (CARA) 100-Day exponential moving average is 0.36, while Cara Therapeutics’s (CARA) share price is $0.34, making it a Sell.
Cara Therapeutics’s (CARA) stock price is $0.34 and Cara Therapeutics’s (CARA) 50-day simple moving average is 0.29, creating a Buy signal.
Cara Therapeutics’s (CARA) stock price is $0.34 and Cara Therapeutics’s (CARA) 100-day simple moving average is 0.31, creating a Buy signal.
Cara Therapeutics’s (CARA) stock price is $0.34 and Cara Therapeutics’s (CARA) 200-day simple moving average is 0.52, creating a Sell signal.

Cara Therapeutics (CARA) Technical Indicators

Nov 10, 2024, 12:30 AM
Name
Value
Implied Action
RSI (14)
68.64
Neutral
STOCH (9,6)
77.08
Neutral
STOCHRSI (14)
78.46
Neutral
MACD (12,26)
0.01
Sell
ADX (14)
29.28
Neutral
Williams %R
-23.73
Buy
CCI (14)
198.86
Sell
ATR (14)
0.03
-
Ultimate Oscillator
53.37
Neutral
ROC
30.77
Buy
Cara Therapeutics’s (CARA) Relative Strength Index (RSI) is 68.64, creating a Neutral signal.
Cara Therapeutics’s (CARA) Trend Strength Indicator (ADX) is 29.28, creating a Neutral signal.
Cara Therapeutics’s (CARA) Commodity Channel Index (CCI) is 198.86, creating a Sell signal.
Cara Therapeutics’s (CARA) Price Rate of Change (ROC) is 30.77, creating a Buy signal.

FAQ

Is CARA a Buy, Hold, or Sell?
Based on CARA’s technical indicators, CARA is a Buy.
    What is CARA’s RSI (14)?
    CARA’s RSI (14) is 68.64, which suggests CARA is a Neutral.
      What is CARA’s MACD?
      CARA’s MACD is 0.01, which suggests CARA is a Sell.
        What is CARA’s 5-day moving average?
        CARA’s 5-day moving average is 0.31, which suggests CARA is a Buy.
          What is CARA’s 20-day moving average?
          CARA 20-day moving average is 0.28, which suggests CARA is a Buy.
            What is CARA’s 50-day moving average?
            CARA’s 50-day moving average is 0.29, which suggests CARA is a Buy.
              What is CARA’s 200-day moving average?
              CARA’s 200-day moving average is 0.52, which suggests CARA is a Sell.
                What is CARA’s Williams % R (14)?
                CARA’s Williams % R (14) is -23.73, which suggests CARA is a Buy.
                  What is CARA’s CCI (14)?
                  CARA’s CCI (14) is 198.86, which suggests CARA is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis